Autopsy report · NCT02282904
Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide
Cause of deathNo reason given
Life of this trial
- Ran for about 5 years 2 months before it stopped.
- 7 participants enrolled.
- Results were posted on the registry 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Sponsor type
- US National Institutes of Health
- Conditions
- Chronic Granulomatous Disease
- Interventions
- Sirolimus; Donor peripheral blood stem cells.; Cyclophosphamide post transplant; Total body 200cGy; Cyclophosphamide; Fludarabine
- Participants
- 7
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.